Seemeen Hassan

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Warfarin was the only oral anticoagulant available for the treatment of venous thromboembolism for about half a century until the recent approval of novel oral agents dabigatran, rivoraxaban and apixaban. This presents new classes of medications less cumbersome to use. They do not require frequent laboratory monitoring or have nurmerous drug interactions.(More)
  • 1